EbsArgent patented in Europe

We are incredibly proud to announce that the fundamental aspects of our EbsArgent®️ antimicrobial technology has been awarded with a granted patent by the European Patent Office (EPO)! The granted patent EP3548043B1, protects the composition of matter and therapeutic and non-therapeutic uses thereof until 2037. A corresponding patent has previously also been granted as US 10,653,717 in the USA.